Véronique LADEVEZE

Dr. Véronique LADEVEZE


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Genes
Verified
Journal Article
Open access
PDF file
AEAyman EL-Seedy
Ayman EL-Seedy
LPLuc Pellerin
Luc Pellerin
GPGuylene Page
Guylene Page
VLVéronique LADEVEZE
Véronique LADEVEZE
The monocarboxylate transporter 4 (MCT4; Slc16a3) is expressed in the central nervous system, notably by astrocytes. It is implicated in lactate release and the regulation of glycolytic flux. Whether its expression varies during normal and/or pathological aging is unclear. As the presence of its mature transcript in the brain of young and old mice was determined, an unexpectedly longer RT-PCR fragment was detected in the mouse frontal cortex and hippocampus at 12 vs. 3 months of age. Cultured astrocytes expressed the expected 516 base pair (bp) fragment but treatment with IL-1β to mimic inflammation as can occur during aging led to the additional expression of a 928 bp fragment like that seen in aged mice. In contrast, cultured pericytes (a component of the blood–brain barrier) only exhibited the 516 bp fragment. Intriguingly, cultured endothelial cells constitutively expressed both fragments. When RT-PCR was performed on brain subregions of an Alzheimer mouse model (APPswePS1dE9), no fragment was detected at 3 months, while only the 928 bp fragment was present at 12 months. Sequencing of MCT4 RT-PCR products revealed the presence of a remaining intron between exon 2 and 3, giving rise to the longer fragment detected by RT-PCR. These results unravel the existence of intron retention for the MCT4 gene in the central nervous system. Such alternative splicing appears to increase with age in the brain and might be prominent in neurodegenerative diseases such as Alzheimer’s disease. Hence, further studies in vitro and in vivo of intron 2 retention in the Slc16a3 gene transcript are required for adequate characterization concerning the biological roles of Slc16a3 isoforms in the context of aging and Alzheimer’s disease pathology.

8 September 2024 in Cellular and Molecular Biology
Verified
Journal Article
Open access
PDF file
AEAyman EL-Seedy
Ayman EL-Seedy
VLVéronique LADEVEZE
Véronique LADEVEZE
Cystic fibrosis (CF) is inherited by CFTR (cystic fibrosis transmembrane conductance regulator) gene mutations. A variety of mutations have been identified in the CFTR gene that may be associated with cystic fibrosis, and these mutations demonstrate extensive molecular genetic heterogeneity in this disease. Little is known about the molecular mechanism by which mutations affect CFTR function, and only a minority of mutations have been characterized by functional studies. There has been an increase in the number of complex alleles. This may partly explain the difficulty in establishing genotype-phenotype correlations and complicate genetic counseling and diagnosis in some cases. Therefore, the identification of complex alleles has several important implications for recessive disorders. This will facilitate diagnosis; improve judgements concerning prognosis, and enable appropriate genetic counselling for affected families. This review describes the complex cystic fibrosis allele to better understand the contribution of this allele in the wide phenotypic variability of cystic fibrosis disease. It occurs in the complex allele that the second cis mutation can modulate the effects of the first mutation or vice versa. The phenotypic variability between CF or CFTR-RD (CFTR related disease) patients may be due to several factors, including different genetic and environmental backgrounds. It is important to determine the allele complex so that optimal treatment can be established.

17 May 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RFRaëd Farhat
Raëd Farhat
GPGéraldine Puissesseau
Géraldine Puissesseau
AEAyman El-Seedy
Ayman El-Seedy
MPMarie-Claude Pasquet
Marie-Claude Pasquet
CACatherine Adolphe
Catherine Adolphe
VLVéronique LADEVEZE
Véronique LADEVEZE
Cystic Fibrosis is the most common recessive autosomal rare disease found in Caucasians. It is caused by mutations on the Cystic Fibrosis Transmembrane Conductance Regulator gene (CFTR) that encodes a protein located on the apical membrane of epithelial cells. c.3909C>G (p.Asn1303Lys, old nomenclature: N1303K) is one of the most common worldwide mutations. This mutation has been found at high frequencies in the Mediterranean countries with the highest frequency in the Lebanese population. Therefore, on the genetic level, we conducted a complete CFTR gene screening on c.3909C>G Lebanese patients. The complex allele c.[744-33GATT(6); 869

22 May 2023
Verified
Journal Article
Open access
PDF file
AEAyman S. El-Seedy
Ayman S. El-Seedy
MBMariam H. Botros
Mariam H. Botros
GPGuylène Page
Guylène Page
VLVéronique LADEVEZE
Véronique LADEVEZE
Human dopamine transporter gene (SLC6A3) is one of the neurotransmission genes that plays an important role in controlling the behavior and psychological reactions toward various physical activities. The aim of the present study is to evaluate the associations between SLC6A3 3’-UTR VNTR (3’VNTR) genotypes and eight personality traits in Egyptian athletes. One hundred athletes (50 males and 50 females) and one hundred non-athletes participated in this investigation either in individual or team games. The Freiburg Personality inventory-Revised questionnaire was applied to athletes to evaluate personality traits according to the scale, at a scheduled time, using descriptive analysis. Genotyping for SLC6A3 3’-UTR VNTR polymorphism in athletes was realized to detect the different genotypes by PCR amplifications using desired primers. Three different genotypes of the 3’VNTR polymorphism; namely (9/9), (9/10), (10/10) were identified. The 9/10 and 10/10 genotypes of SLC6A3 gene were significantly higher in players than those in the control group. There were no statistically significant differences in personality traits values among males and females. The Cronbach’s alpha stability coefficient for four items is higher than 0.7 suggesting that these items (Neuroticism, Aggressiveness, Depression and Excitability) have a good reliability and support the used personality dimensions for this investigation. Our findings revealed a significant association between the genotypes of 3’VNTR and the personality traits in Egyptian athletes. These data shed light on the role of SLC6A3 gene in athletes’ behavioral performance and could serve as the basis for further characterization in the large number of Egyptian athletes.

31 March 2017 in Frontiers in Genetics
Verified
Journal Article
Open access
AEAyman S. El-Seedy
Ayman S. El-Seedy
HSHanaa Shafiek
Hanaa Shafiek
AKAlain Kitzis
Alain Kitzis
VLVéronique LADEVEZE
Véronique LADEVEZE
Cystic Fibrosis (CF) is the most common lethal rare genetic disease in the Caucasian populations. It is caused by a variety of sequence alterations in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene. In Caucasian, one over 3,500 new born children suffers from the disease and one over 30 of them is at least carrier of a severe mutation in the CFTR gene. CF and CFTR-related disorders (CFTR-RDs) are two distinct clinical outcomes of the gene mutations. The CF mutation induces a severe phenotype involving different organs, whereas a CFTR-RD mutation induces less life-threatening symptoms with three main clinical entities including congenital bilateral absence of the vas deferens (CBAVD), acute recurrent or chronic pancreatitis, and disseminated bronchiectasis (Bombieri et al., 2011). In the Arab countries, the spectrum of CF mutations, incidence and prevalence of the disease are largely unknown in the Arab populations (Wei et al., 2006). This is due to the lack of disease awareness, and diagnosis facilities that mislead the identification of CF during many decades. Additionally, epidemiological studies that realized were revealed a distinguished mutational spectrum between Arab countries if compared to White-European populations. Furthermore, Arab Mediterranean countries have a different CFTR mutational profile if compared to the Arabian Peninsula. Egypt as Mediterranean North African country, this strategic position attracted many invaders throughout its history. Therefore, in addition to its Pharaonic origin, gene flow to its population occurred from the Ethiopian, Greco-Roman, Arab, Turkish, French and English settlers (Temtamy et al., 2010). The common heritage among the countries bordering the Mediterranean is not restricted to historical or cultural aspects. There are considerable commonalities in the gene pools of the Mediterranean Northern and Southern countries. This “genetic sharing” has resulted from considerable human movements (i.e., migration, invasion, and trade) throughout history in this area (Temtamy et al., 2010). Consequently, Egypt is not like other Arab countries and mutations in the CFTR gene have been influenced by gene flow coming from different populations. Furthermore, the high rate of consanguinity, infant and neonatal mortality in the Egyptian society will, therefore, increase CF incidence and private mutations. Indeed, another important issue is the increase number of CFTR-related disorders patients such as idiopathic bronchiectasis, congenital bilateral absence of the vas deferens, idiopathic (non-alcoholic) pancreatitis, and severe sinusitis in the Egyptian population. This observation is in agreement with data previously published (Lissens et al., 1999; Hussein et al., 2011; Fathy et al., 2016). In Egypt, there is no available data on the nature and frequency of CF gene mutations. There are a few previous reports of CFTR gene mutations in Egyptian patients that have been published. In these papers, a CF screening strategy of CFTR mutations was realized using commercial kits or a panel defined by the American College of Medical Genetics and Genomics (ACMG) and American College of Obstetricians and Gynecologists (ACOG), (Naguib et al., 2007; El-Falaki et al., 2014; Fathy et al., 2016; Shahin et al., 2016), which is not suitable for screening of the CFTR gene mutations in the Egyptian population. This emphasizes the need for establishing a correct genetic screening for CF mutations in Egyptian patients and to determine the carrier status in their healthy relatives. In our recent study, we have performed a complete CFTR gene screening in CF or CFTR-RD patients from Alexandria, Northern Egypt, by direct sequencing of the entire CFTR gene that identified four novel CF mutations in the CFTR gene amongst 13 other known mutations in the other populations (Figure 1A). Furthermore, this is the first comprehensive profile of CFTR gene mutations and their corresponding haplotypes in the Egyptian population (El-Seedy et al., 2016). Besides, CFTR mutations in the other Egyptian regions have not been analyzed. Thus, the identification of CFTR mutations is become increasingly important in genetic counseling and prenatal diagnosis particularly in families with multiple affected children (Wang et al., 2000). Figure 1. Mutational spectrum of CFTR gene mutations in the Egyptian population. (A) CFTR mutations identified in our recent investigation of Egyptian CF or CFTR-RD patients from Alexandria city, Northern Egypt which performed a complete CFTR gene screening by direct sequencing of the entire CFTR gene. This study is the first to identify novel mutations (indicated with a star*) in the Egyptian population amongst 13 other known mutations that appear to be a specific to Egyptian CF patients (2); (B) a panel of the most common mutations detected in the Egyptian population; (C) intronic mutations identified in the Egyptian patients that will be also present in the panel. According to available data of CFTR gene mutations, we propose general national screening panel comprising 27 mutations reported in Egyptian patients until now. This will help to detect about 50% of CFTR gene mutations in Egypt and further extensive studies will help to improve this panel. The establishment of the first panel of the CFTR gene mutations in the Egyptian population (Figures 1B,C) will help physicians for designing an appropriate strategy for future genetic diagnosis for patients and families at risk. In this regard, defining a population-specific mutational panel for CF in Egyptian population including: c.92G>A (exon 2), c.454A>T (exon 4), c.902A>G (exon 8), c.1418delG (exon 11), c.2620-15C>G (intron 15), c.2782G>C (exon 17),...

1 July 2013 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
AEAyman El-Seedy
Ayman El-Seedy
MPMarie-Claude Pasquet
Marie-Claude Pasquet
TBThiery Bienvenu
Thiery Bienvenu
EBEric Bieth
Eric Bieth
MAMarie-Pierre Audrezet
Marie-Pierre Audrezet
VLVéronique LADEVEZE
Véronique LADEVEZE